About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
Company Profile Why Invest? Events Calendar Management Views Financial Reporting Shareholder Information
Q4
Down Arrow
Q3
Q2
Q1
Contact IR
 
TSX:  $17.22 (-0.72)
NYSE:  $13.61 (-0.89)
  15 minute delay
Uranium Price
Print Page
Print Page

Balance Sheet

Consolidated Balance Sheets
(Unaudited)
(In Thousands)

    As At
     
    Dec 31/02 Dec 31/01  
Assets        
Current assets        
Cash $58,096   $33,737  
  Accounts receivable 186,369   255,963  
  Inventories 339,684   354,384  
  Supplies and prepaid expenses 45,731   44,574  
Current portion of long-term receivables, investments and other 20,163   30,304  
    650,043   718,962  
         
  Property, plant and equipment 2,037,613   1,994,424  
  Long-term receivables, investments and other 257,523   233,961  
  2,295,136   2,228,385  
Total assets $2,945,179   $2,947,347  
           
Liabilities and Shareholders' Equity        
Current liabilities        
Accounts payable and accrued liabilities $131,932   $108,096  
  Dividends payable 6,998   6,959  
Current portion of long-term debt 6,318   26,189  
Current portion of other liabilities 16,931   4,182  
  Future income taxes 9,198   21,311  
    171,377   166,737  
       
  Long-term debt 218,290   327,773  
  Provision for reclamation 155,036   139,583  
  Other liabilities 9,523   9,787  
  Future income taxes 522,979   480,520  
    1,077,205   1,124,400  
       
  Minority interest 18,078   -  
         
Shareholders' equity        
  Preferred securities 193,763   195,229  
  Share capital 680,934   670,031  
  Contributed surplus 472,488   472,488  
  Retained earnings 483,658   465,420  
  Cumulative translation account 19,053   19,779  
  1,849,896   1,822,947  
Total liabilities and shareholders' equity $2,945,179   $2,947,347  

 

See accompanying notes to consolidated financial statements